Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization

Bevacizumab is an anti-vascular endothelial growth factor drug that can be used to treat choroidal neovascularization (CNV). Bevacizumab-loaded multivesicular liposomes (Bev-MVLs) have been designed and developed to increase the intravitreal retention time of bevacizumab and reduce the number of inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Hongjie, Wang, Yiyun, Chu, Yongchao, Jiang, Ying, Hua, Hongchen, Chu, Liuxiang, Wang, Kaili, Wang, Aiping, Liu, Wanhui, Li, Youxin, Fu, Fenghua, Sun, Kaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058521/
https://www.ncbi.nlm.nih.gov/pubmed/29869520
http://dx.doi.org/10.1080/10717544.2018.1474967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058521/
https://www.ncbi.nlm.nih.gov/pubmed/29869520
http://dx.doi.org/10.1080/10717544.2018.1474967

Ejemplares similares